Table 2 Point prevalence study: sedative and analgesic agents received
From: National survey and point prevalence study of sedation practice in UK critical care
Received | Highest rate of infusion (mg/h) | Total dose (mg) | |||
|---|---|---|---|---|---|
n (%) | Reported, n | Mean (SD)a | Reported, n | Mean (SD)a | |
Sedative agent | |||||
Propofol | 174 (71.9) | 162 | 138 (87) | 172 | 2052 (1734) |
Haloperidol | 8 (3.3) | 1 | – | 8 | 6.6 (3.8) |
Midazolam | 21 (8.7) | 16 | 7.1 (4.8) | 21 | 97.2 (121.5) |
Clonidine | 20 (8.3) | 9 | 0.17 (0.18) | 18 | 1.3 (1.9) |
Dexmedetomidine | 4 (1.7) | 3 | – | 3 | – |
Ketamine | 1 (0.4) | 1 | – | 1 | – |
Diazepam | 4 (1.7) | 0 | – | 4 | – |
Lorazepam | 3 (1.2) | 0 | – | 2 | – |
Olanzapine | 2 (0.8) | 0 | – | 1 | – |
Thiopentone | 2 (0.8) | 0 | – | 2 | – |
Analgesic agent | |||||
Alfentanil | 76 (31.4) | 74 | 2.3 (1.9) | 76 | 40.9 (36.6) |
Fentanyl | 66 (27.3) | 59 | 0.15 (0.21) | 59 | 1.7 (1.5) |
Remifentanil | 24 (9.9) | 22 | 0.57 (0.63) | 21 | 9.3 (9.6) |
Morphine | 48 (19.8) | 20 | 4.3 (4.5) | 46 | 57.8 (83.8) |